Dopamine agonists, such as ropinirole, bind to and activate dopamine D2 and D3 receptors, which are believed to modulate pain perception and neurovascular regulation in cluster headache pathogenesis. By stimulating these receptors, they can potentially reduce the frequency and intensity of cluster headache attacks through central nervous system mechanisms that alter neuronal signaling and vascular tone.